eslicarbazepine acetate has been researched along with Epileptiform Neuralgia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz-Maroto, I; García-Muñozguren, S; Gracia-Gil, J; Palazón-García, E; Perona-Moratalla, AB; Sanchez-Larsen, A; Segura, T; Sopelana, D | 1 |
| Alcántara Montero, A; Sánchez Carnerero, CI | 1 |
| Micov, A; Pecikoza, U; Stepanović-Petrović, R; Tomić, M | 1 |
3 other study(ies) available for eslicarbazepine acetate and Epileptiform Neuralgia
| Article | Year |
|---|---|
Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Female; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Trigeminal Neuralgia | 2018 |
Comment on a paper by Sanchez-Larsen A et al. 'Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia'.
Topics: Dibenzazepines; Humans; Trigeminal Neuralgia | 2018 |
Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors.
Topics: Adrenergic Antagonists; Analgesics; Animals; Atropine; Cholinergic Antagonists; Dibenzazepines; Formaldehyde; Male; Mice; Naloxone; Narcotic Antagonists; Pain; Receptors, Adrenergic; Receptors, Cholinergic; Receptors, Opioid; Trigeminal Neuralgia; Yohimbine | 2018 |